Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes

NCT ID: NCT07285330

Last Updated: 2025-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-30

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aims to compare the effects on glycated hemoglobin (HbA1c) at 3 months of two care models in patients with type 2 diabetes referred due to poor glycemic control: a day hospital endocrinology care model versus a care model centered on follow-up by a dietitian-nutritionist.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes (DM)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Day Care Hospital

These patients received joint care from a nurse and an endocrinologist in the day hospital before 2024.

Day Care Hospital

Intervention Type OTHER

Clinical follow-up under the joint care of a nurse and an endocrinologist at Day Care Hospital

Nutritionist

These patients received joint care from a nutriotinist and finally an endocrinologist in ambulatory care unit after 2024.

Nutritionist

Intervention Type OTHER

Clinical follow-up with a dietitian-nutritionist and an endocrinologist at ambulatory care unit

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Day Care Hospital

Clinical follow-up under the joint care of a nurse and an endocrinologist at Day Care Hospital

Intervention Type OTHER

Nutritionist

Clinical follow-up with a dietitian-nutritionist and an endocrinologist at ambulatory care unit

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a diagnosis of type 2 diabetes (T2DM) referred to endocrinology due to poor metabolic control.
* Patients on insulin therapy

Exclusion Criteria

* Referred from primary care for other reasons such as hypoglycemia.
* Patients with other types of diabetes mellitus or with uncertainty in diagnostic classification.
* Patients on rapid-acting insulin bolus therapy.
* Patients with acute decompensation of diabetes.
* Patients receiving corticosteroid treatment.
* Dependent individuals for activities of daily living (ADL) with a Barthel index score below 60 or with cognitive impairment.
* Language barrier.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Consorci Sanitari de l'Alt Penedès i Garraf

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital de Vilafranca

Vilafranca del Penedès, Barcelona, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Noemí Casaponsa

Role: CONTACT

+34 938960025 ext. 43197

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Noemí Casaponsa

Role: primary

+34 938960025 ext. 43197

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CSAPG-76

Identifier Type: -

Identifier Source: org_study_id